141 related articles for article (PubMed ID: 30046180)
1. Prethreshold retinopathy of prematurity: VEGF inhibition without VEGF inhibitors.
Gaynon MW; Wong RJ; Stevenson DK; Sunshine P
J Perinatol; 2018 Oct; 38(10):1295-1300. PubMed ID: 30046180
[TBL] [Abstract][Full Text] [Related]
2. Rethinking STOP-ROP: is it worthwhile trying to modulate excessive VEGF levels in prethreshold ROP eyes by systemic intervention? A review of the role of oxygen, light adaptation state, and anemia in prethreshold ROP.
Gaynon MW
Retina; 2006 Sep; 26(7 Suppl):S18-23. PubMed ID: 16946672
[TBL] [Abstract][Full Text] [Related]
3. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes.
Pediatrics; 2000 Feb; 105(2):295-310. PubMed ID: 10654946
[TBL] [Abstract][Full Text] [Related]
4. Retinopathy of prematurity outcome in infants with prethreshold retinopathy of prematurity and oxygen saturation >94% in room air: the high oxygen percentage in retinopathy of prematurity study.
McGregor ML; Bremer DL; Cole C; McClead RE; Phelps DL; Fellows RR; Oden N;
Pediatrics; 2002 Sep; 110(3):540-4. PubMed ID: 12205257
[TBL] [Abstract][Full Text] [Related]
5. Supplemental oxygen may decrease progression of prethreshold disease to threshold retinopathy of prematurity.
Gaynon MW; Stevenson DK; Sunshine P; Fleisher BE; Landers MB
J Perinatol; 1997; 17(6):434-8. PubMed ID: 9447528
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity.
Hartnett ME
Clin Perinatol; 2014 Dec; 41(4):925-43. PubMed ID: 25459781
[TBL] [Abstract][Full Text] [Related]
7. Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology.
Cayabyab R; Ramanathan R
Neonatology; 2016; 109(4):369-76. PubMed ID: 27251645
[TBL] [Abstract][Full Text] [Related]
8. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
Sankar MJ; Sankar J; Mehta M; Bhat V; Srinivasan R
Cochrane Database Syst Rev; 2016; 2():CD009734. PubMed ID: 26932750
[TBL] [Abstract][Full Text] [Related]
9. Effects of oxygen on the development and severity of retinopathy of prematurity.
Hartnett ME; Lane RH
J AAPOS; 2013 Jun; 17(3):229-34. PubMed ID: 23791404
[TBL] [Abstract][Full Text] [Related]
10. The lack of association between vascular endothelial growth factor and retinopathy of prematurity in an observational study.
Kandasamy Y; Hartley L; Rudd D; Smith R
J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2202-2208. PubMed ID: 28573924
[TBL] [Abstract][Full Text] [Related]
11. Retinopathy of prematurity: an eye toward better outcomes.
Pollan C
Neonatal Netw; 2009; 28(2):93-101. PubMed ID: 19332407
[TBL] [Abstract][Full Text] [Related]
12. Role of VEGF Inhibition in the Treatment of Retinopathy of Prematurity.
Eldweik L; Mantagos IS
Semin Ophthalmol; 2016; 31(1-2):163-8. PubMed ID: 26959143
[TBL] [Abstract][Full Text] [Related]
13. An Update on Retinopathy of Prematurity (ROP).
Dogra MR; Katoch D; Dogra M
Indian J Pediatr; 2017 Dec; 84(12):930-936. PubMed ID: 28674824
[TBL] [Abstract][Full Text] [Related]
14. Retinopathy of prematurity.
Chen J; Smith LE
Angiogenesis; 2007; 10(2):133-40. PubMed ID: 17332988
[TBL] [Abstract][Full Text] [Related]
15. The association between systemic vascular endothelial growth factor and retinopathy of prematurity in premature infants: a systematic review.
Kandasamy Y; Hartley L; Rudd D; Smith R
Br J Ophthalmol; 2017 Jan; 101(1):21-24. PubMed ID: 27388246
[TBL] [Abstract][Full Text] [Related]
16. Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity.
Vanderveen DK; Mansfield TA; Eichenwald EC
J AAPOS; 2006 Oct; 10(5):445-8. PubMed ID: 17070480
[TBL] [Abstract][Full Text] [Related]
17. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.
Pierce EA; Foley ED; Smith LE
Arch Ophthalmol; 1996 Oct; 114(10):1219-28. PubMed ID: 8859081
[TBL] [Abstract][Full Text] [Related]
18. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity.
Stone J; Chan-Ling T; Pe'er J; Itin A; Gnessin H; Keshet E
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):290-9. PubMed ID: 8603833
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors of retinopathy of prematurity in extremely low birth weight infants by strictly controlling oxygen inhalation after birth].
Mao JB; Yu XT; Shen LJ; Wu MY; Lyu Z; Lao JM; Li HX; Wu HF; Chen YQ
Zhonghua Yan Ke Za Zhi; 2019 Apr; 55(4):280-288. PubMed ID: 30982290
[No Abstract] [Full Text] [Related]
20. VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity.
Pieh C; Agostini H; Buschbeck C; Krüger M; Schulte-Mönting J; Zirrgiebel U; Drevs J; Lagrèze WA
Br J Ophthalmol; 2008 May; 92(5):689-93. PubMed ID: 18408080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
